Elsevier

Bioorganic & Medicinal Chemistry

Volume 16, Issue 22, 15 November 2008, Pages 9790-9794
Bioorganic & Medicinal Chemistry

Structure–activity relationship of antibacterial chalcones

https://doi.org/10.1016/j.bmc.2008.09.064Get rights and content

Abstract

The antibacterial activity of 31 chalcones was tested against bacterial strains, Bacillus cereus ATCC 11778, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Staphylococcus aureus ATCC 25923. Some of the tested chalcones showed fair to significant activity against Gram-positive bacteria. By comparison of the results obtained, the antibacterial activity can be related to features such as the presence of a C-4 hydroxyl group, a C-4′ oxygenated substituent or a C-3′ isoprenoid side chain, while the C-2′ hydroxyl group might have importance for the stability of the molecule. The inhibitory effect of chalcones on human pathogenic microorganisms can be correlated with the substitution patterns of the aromatics rings.

Graphical abstract

The antibacterial activity of thirty-one chalones is described. Some of the tested compounds showed fair to significant activity against Gram-positive bacteria.

  1. Download : Download full-size image

Introduction

Flavonoids represent an outstanding class of naturally occurring compounds with a 1,3-diarylpropane skeleton, which may assume different cyclic or alicyclic arrangements, according to varying levels of oxidation. Chalcones are open chain flavonoids in which two aromatic rings are joined by a three carbon α,β-unsaturated carbonyl system, that is, 1,3-diphenyl-2-propen-1-one derivatives. The equilibrium between the open chalcone form and the cyclic flavanone isomer is the key step at the origin of the skeletal modifications of the biosynthetic pathway. Chalcones have shown a wide variety of anticancer,1 antiinflammatory,2 antiinvasive,3 and antifungal activities.4 In addition to the properties listed above, the antibacterial activity of chalcones is being increasingly documented. Depending on the substitution of the two aromatic rings the chalcones can display different spectra of activity. For instance, (E)-chalcones containing 4-alkylthio- or 4-alkoxy side chains and 4′-N-piperidine or 4′-N-methylpiperidine groups, as para substituents, exhibited a narrow spectrum of antibacterial activity, being affective against Gram-positive bacteria.5 Conversely, broad-spectrum compounds, effective against Gram-positive and Gram-negative bacteria, were obtained by introduction of piperazine or 2,5-dichlorothiophene on the basic skeleton of the chalcones.6 Finally, 5-[3-(4′-dimethylaminophenyl)acryolyl]-6-methoxybenzo-[1,3]-oxathiol-2-one was shown to display tuberculostatic activity against Mycobacterium tuberculosis.7 In earlier studies, concerning their antimicrobial effect, the activity of chalcones was mainly attributed to the presence of phenolic hydroxyl groups, which have high affinity for proteins and thus may inhibit microbial enzymes.8 It was generally agreed that at least one phenolic hydroxyl group and a certain degree of lipophilicity were required.9 The nature of the flavonoid was considered priority, e.g., the flavanone isoxanthoumol is 60 times less active than the corresponding chalcone,10 but the influence of the substitution pattern on the structure–activity relationship (SAR) was not further investigated. By contrast, a SAR study on the effect of 12 different chalcones, on both established and primary ovarian cancer cells, revealed some important remarks on the influence that structural changes may have on both antiproliferative and binding activity.11 This paper deals with an investigation on the influence of the substitution pattern, involving hydroxyl, methoxyl, acetoxyl, and methyledioxy groups as well as isoprenoid substituents, of both A and B rings of 31 chalcones on their antibacterial activity against human pathogenic microorganisms.

Section snippets

Results and discussion

Table 1 summarizes the results obtained for the MICs and MBCs of the 31 chalcones (Figs. 1 and 2) against the four bacterial species.

Although no definite structure–activity relationship could be determined, some conclusions on the structural changes that may influence the antimicrobial activity can be drawn by the comparison among the structures of compounds with different activities:

  • 4-Hydroxyderricin (18) was the most active compound, followed by 2′,4,4′-trihydroxy-3-prenyl-3′-geranylchalcone (

Conclusion

These studies, focused on the potentially active skeleton of chalcones, pointed out the importance of the positions of the phenolic hydroxyl groups and/or the isoprenyl side chain in the substitution pattern. The importance of prenyl and/or geranyl groups, which confer to the molecule a strong affinity to biological membranes14 must be once again noticed.15

Chalcones

Thirty-one natural and/or synthetic chalcones, available in our laboratories, have been assayed in this study. The chalcones (compounds 110 and 27) and dihydrochalcones (compounds 2831) were earlier synthesized by Professor G. Bargellini (1879–1963) and co-worker at beginning of 20th century.16, 17, 18, 19 Afterwards, the compounds were inherited by Professor G.B. Marini Bettolo (1915–1996) and finally exhumed by one of us (F. Delle Monache). Their structures, initially suggested by the

Acknowledgments

We thank Giuliano Delle Monache for a discussion of the manuscript. This work was supported by Fundação de Apoio à Pesquisa Científica e Tecnológica do Estado de Santa Catarina (FAPESC) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).

References and notes (24)

  • Y.K. Rao et al.

    Bioorg. Med. Chem.

    (2004)
  • H.H. Ko et al.

    Bioorg. Med. Chem.

    (2003)
  • V.S. Parmar et al.

    Bioorg. Med. Chem.

    (2003)
  • S.N. Lopez et al.

    Bioorg. Med. Chem.

    (2001)
  • Z. Nowakowska et al.

    Schroeder. Eur. J. Med. Chem.

    (2008)
  • V. Tomar et al.

    Bioorg. Med. Chem. Lett.

    (2007)
  • D. Barron et al.

    Phytochemistry

    (1996)
  • N. Selvakumar et al.

    Eur. J. Med. Chem.

    (2007)
  • M.D. Konieczny et al.

    Chem. Pharm. Bull.

    (2007)
  • D. Prusky et al.

    Plant Dis.

    (1993)
  • E. Laks et al.

    Phytochemistry

    (1989)
  • R. De Vincenzo et al.

    Anti-Cancer Drug Des.

    (1995)
  • Cited by (0)

    View full text